Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00700414 · ClinicalTrials.gov registry record

International Pediatric Adrenocortical Tumor Registry

A clinical trial of Adrenocortical Tumor, sponsored by St. Jude Children's Research Hospital.

Recruiting
Registry status
5
Study locations

NCT00700414 is a study of Adrenocortical Tumor that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registry lists this as an open-ended (no fixed target) study. The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00700414, a study of Adrenocortical Tumor, is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.

RECRUITING
Registry status
open-ended (no fixed target)
Enrollment target
5
Study locations

Study Summary

This study aims to collect demographic and medical information including detailed family history of cancer of children and adolescents with adrenocortical tumors in order to learn more about the clinical and epidemiological aspects, treatment modalities, and outcome of patients with this rare disease, worldwide. In addition, investigators at St. Jude Children's Research Hospital (SJCRH) plan to perform molecular studies of tumor cells aimed to clarify the role of the TP53 gene and other genetic pathways in these tumors. They aim to obtain relevant biological material from participants with adrenocortical tumor (ACT), their biological parents, and relatives for determination of the TP53 germline status, molecular studies of the TP53 gene, and other molecular pathways.

Conditions Studied

Study Locations (5)

California

  • Stanford University - Stanford

Florida

  • All Children's Hospital/St. Petersburg Hospital - St. Petersburg

Ohio

  • The Children's Medical Center - Dayton

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Texas

  • Cook Children's Medical Center - Fort Worth

Trial Details

FieldValue
Enrollment Target open-ended (no fixed target)
Start Date 2001-10-01
Est. Completion 2040-12

What the Registry Record Tells You About NCT00700414

The ClinicalTrials.gov registry entry for NCT00700414 describes a study currently listed as recruiting, categorized as an unspecified phase. The registry lists this as an open-ended (no fixed target) study, common for long-running registries and repositories that collect data indefinitely rather than recruiting toward a fixed participant count. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Adrenocortical Tumor appearing as the primary indexed condition, and to 0 interventions.

NCT00700414 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Florida, Ohio.

Frequently Asked Questions

What is clinical trial NCT00700414 about?

NCT00700414 is a clinical study titled "International Pediatric Adrenocortical Tumor Registry". This study aims to collect demographic and medical information including detailed family history of cancer of children and adolescents with adrenocortical tumors in order to learn more about the clinical and epidemiological aspects, treatment modalities, and outcome of patients with this rare diseas...

What is the current status of trial NCT00700414?

This trial is currently recruiting. The enrollment target is open-ended (no fixed target). The study started on 2001-10-01. Estimated completion is 2040-12.

What conditions does trial NCT00700414 study?

This clinical trial studies the following conditions: Adrenocortical Tumor.

Who is sponsoring clinical trial NCT00700414?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00700414 being conducted?

This trial has 5 study locations across California, Florida, Ohio, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.